Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor γ-independent regulation of nucleophosmin-Reference-Cited by-同舟云学术

Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor γ-independent regulation of nucleophosmin

Published:2010-03-15 Issue:2 Volume:52 Page:493-505
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Galli Andrea,Ceni Elisabetta,Mello Tommaso,Polvani Simone,Tarocchi Mirko,Buccoliero Francesca,Lisi Francesca,Cioni Laura,Ottanelli Barbara,Foresta Valeria,Mastrobuoni Guido,Moneti Gloriano,Pieraccini Giuseppe,Surrenti Calogero,Milani Stefano

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23669/fullpdf

Reference45 articles.

1. Estimating the world cancer burden: Globocan 2000;Parkin;Int J Cancer,2001

2. Design and endpoints of clinical trials in hepatocellular carcinoma;Llovet;J Natl Cancer Inst,2008

3. Thiazolidinediones: effects on insulin resistance and the cardiovascular system;Quinn;Br J Pharmacol,2008

4. Peroxisome proliferator activated-receptor γ: a versatile metabolic regulator;Rocchi;Ann Med,1999

5. The potential of anti-diabetic thiazolidinediones for anticancer therapy;Galli;Expert Opin Investig Drugs,2006

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth;Translational Oncology;2024-09

2. The effects of pioglitazone and rosiglitazone on liver function in hypothyroid rats;Journal of Complementary and Integrative Medicine;2024-01-22

3. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma;World Journal of Gastroenterology;2023-01-14

4. Coumarin-4-yl‐1,2,3‐triazol‐4-yl-methyl-thiazolidine-2,4-diones: Synthesis, glucose uptake activity and cytotoxic evaluation;Bioorganic Chemistry;2023-01

5. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios;World Journal of Gastroenterology;2022-07-28